Salmonella typhi Ty21a live antigen 2000000000 UNT Delayed Release Oral Capsule [Vivotif]
RxNorm concept 762602, branded drug (sbd). Prescribable name: Vivotif 2,000,000,000 UNT Delayed Release Oral Capsule.
- RxCUI
- 762602
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/762602 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Vivotif 2,000,000,000 UNT Delayed Release Oral Capsule; Vivotif Berna 2,000,000,000 UNT Delayed Release Oral Capsule
Related concepts
- Salmonella typhi Ty21a live antigen 2000000000 UNT (SCDC, consists of)
- Salmonella typhi Ty21a live antigen 2000000000 UNT [Vivotif] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Vivotif (BN, has ingredient)
- Salmonella typhi Ty21a live antigen 2000000000 UNT Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
- 50090229200
- 50090229209
- 50632001602
- 50632001604
- 58337000301
- 68071133904
- 69401000001
- 69401000002
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 762602 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/762602 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 762602. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.